Richard Penuliar

Richard Penuliar has over 30 years of work experience in the pharmaceutical and biotechnology industry. Richard is currently working as a Senior Scientist in Drug Substance Process Development at Ventyx Biosciences since March 2023. Prior to this, from January 2019 to December 2022, Richard worked as a Senior Drug Substance Development Scientist at Arena Pharmaceuticals, Inc. There, they served as the technical lead and primary contact collaborating with three different contract manufacturing organizations (CMOs) simultaneously to manufacture regulatory materials for Arena's Phase 3 API. Richard also contributed to regulatory filings and provided source documents.

Before Arena Pharmaceuticals, Richard worked as a Scientist in Process Development Chemistry at La Jolla Pharmaceutical Company from April 2018 to December 2018. In this role, they helped develop the process for a small molecule precursor and manufactured intermediate materials for a GMP campaign at a CMO.

Richard also gained experience as a Senior Associate Scientist at Dart NeuroScience LLC from December 2012 to February 2018. Prior to that, they worked as a Scientist II at Pacific World Discovery from November 2009 to September 2012, where they synthesized and purified organic compounds for medicinal chemistry and scale-up projects.

Earlier in their career, Richard worked as a Scientist at BioFocus DPI from March 2007 to April 2009, synthesizing small molecule compounds and participating in project discussions with clients. Richard also worked as an Associate Scientist at Ligand Pharmaceuticals from November 2003 to February 2007 and as a Senior Research Associate at Chugai Pharma USA from March 2001 to July 2003.

Richard's earlier experience includes working as a Senior Research Associate at Cytel Corporation from March 1994 to March 2001, where they focused on carbohydrate drug development and performed kilo-scale enzymatic cycles. Richard also worked as a Process Chemist at Greenwich Pharmaceuticals Inc from January 1991 to February 1994, specializing in the development of carbohydrate drugs.

Overall, Richard Penuliar has a diverse range of experience in drug substance development, process development chemistry, and medicinal chemistry, with a strong background in carbohydrate drug development.

Richard Penuliar attended Penn State University from 1986 to 1991, where they obtained a Bachelor of Science degree in Chemistry.